{
  "id": 7229440,
  "title": "Telix Pharma wins FDA approval for brain cancer treatment, shares surge",
  "url": "https://urgent.news/2026/09/14/telix-pharma-wins-fda-approval-for-brain-cancer-treatment-shares-surge",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T02:28:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/telix-pharma-wins-fda-approval-for-brain-cancer-treatment-shares-surge-4898794"
  },
  "original_language": "en",
  "account": "Telix Pharmaceuticals Ltd (ASX:TLX) announced on Monday that the U.S. Food and Drug Administration had granted approval for its brain cancer imaging drug Pixclara, leading to a significant surge in its Australian shares. The company's stock rose as high as 12% to A$17.65 in the Sydney trade before settling at a 2.6% gain by 21:55 ET (01:55 GMT).\n\nThe FDA's approval of Telix's new drug application for the treatment marks a major breakthrough, making Pixclara widely accessible in the United States. Pixclara is a radioactive diagnostic drug specifically designed for glioma, a prevalent form of brain cancer. This is the first of its kind to receive FDA approval in the U.S., positioning Telix to tap into a new revenue stream.\n\nThe FDA approval is anticipated to substantially boost Telix's market presence in the U.S., generating a surge in its shares. To date in 2026, Telix shares have already increased by nearly 43%.",
  "summary": null,
  "key_points": [
    "FDA approves Telix Pharma's brain cancer treatment Pixclara",
    "Telix shares surge 12% to A$17.65 in Sydney trade",
    "First FDA-approved radioactive diagnostic drug for glioma"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "FDA approves Telix brain cancer imaging drug Pixclara",
        "url": "https://urgent.news/2026/09/14/fda-approves-telix-brain-cancer-imaging-drug-pixclara",
        "published": "2026-09-14T00:34:11.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}